Last updated on September 2007

PPI-Rebound-Trial. A Study of the Clinical Relevance of the Acid Rebound Phenomena


Brief description of study

The acid secretion in the stomach seems to increase after withdrawal of min. 8 wks of treatment with a PPI (protonpump inhibitor) It is unknown if this acid rebound phenomenon is of clinical significance. In a doubleblinded and placebocontrolled study healthy volunteers are randomized to treatment with placebo or PPI + placebo. Gastrointestinal symptoms are scored once a week and.

Clinical Study Identifier: NCT00526006

Contact Investigators or Research Sites near you

Start Over

Chrístina Reimer, MD

University Hospital K gw
Koge, Denmark
  Connect »

Recruitment Status: Open


Brief Description Eligibility Contact Research Team


Receive Emails About New Clinical Trials!

Sign up for our FREE service to receive email notifications when clinical trials are posted in the medical category of interest to you.